SPOTLIGHT: Church & Dwight to buy Del Labs' drugs

Coty is selling off the pharma business of Del Laboratories, which makes Orajel, for $380 million to Church & Dwight of Arm & Hammer fame. The deal comes three years after Church & Dwight walked away from an agreement to buy Del Labs with a private-equity firm. Release

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.